Le Lézard
Classified in: Ebola virus, Health, Business
Subjects: ERN, ACC

Essity: Year-end Report 2022


STOCKHOLM, Jan. 26, 2023 /PRNewswire/ -- 

JANUARY 1 ? DECEMBER 31, 2022 
(compared with the corresponding period a year ago)

CEO'S COMMENTS

Record growth, significant price increases and acquisitions

"In 2022, Essity achieved record growth and its highest net sales ever. We can see that, despite significant cost inflation, we achieved an operating profit, before depreciation, amortization and impairment, that was in line with 2021. We implemented significant price increases, while volumes were higher for the year."

Strong sales growth with significant price increases

Essity's net sales for 2022 amounted to approximately SEK 156bn. Sales growth, including organic sales growth and acquisitions, was strong and amounted to 17.7% and the average price increase was 13.3%. Sales growth was strong in all three business areas: Health & Medical, Consumer Goods and Professional Hygiene, which are all leading in a growing global hygiene and health market. Despite significant price increases, volumes were higher for the year. Work to improve efficiency has progressed at a high pace. Adjusted EBITA amounted to SEK 13,058m and the adjusted EBITA margin to 8.4%.

The adjusted return on capital employed was 9.7%. Earnings per share were SEK 7.93. For the 2022 fiscal year, the Board of Directors proposes an increase in the dividend of 4% to SEK 7.25 per share.

The year was dominated by the war in Ukraine and the resulting human suffering. Essity has made donations to the UNHCR and other international and local organizations. Work is ongoing to exit the Russian market and the company's assets in Russia have been impaired by approximately SEK 1.7bn.

Fourth quarter 2022 ? Higher earnings and adjusted EBITA margin

In the fourth quarter, net sales increased significantly and amounted to approximately SEK 44bn. Further price increases were implemented and averaged 18.4%, an increase of 6% compared with the third quarter 2022. As a result of our successful work to raise prices, adjusted EBITA increased 33% and the adjusted EBITA margin increased 0.3 of a percentage point to 9.3%. Compared with the third quarter of 2022, the adjusted EBITA margin increased 1.8 percentage points. The adjusted return on capital employed increased to 11.4%.

Acquisitions in fast-growing segments

Three companies were acquired, in line with our strategy to grow in segments with strong future growth. The acquisition of the US company Legacy Converting Inc. will broaden Essity's offering in Professional Hygiene through a stronger position in wiping and cleaning products in the North American market. Two leading companies were acquired in Intimate Hygiene: Knix Wear Inc. and Modibodi. Essity is now a global market leader1) within leakproof apparel, which is the fastest growing product segment in Intimate Hygiene.

A winning offering

We continued to invest in innovation and marketing to increase the share of premium offerings, sustainable solutions and digital offerings. In 2022, Essity's e-commerce sales increased by 20% to SEK 23bn, corresponding to 15% of net sales. We also increased the company's direct-to-consumer sales through investments and acquisitions.

1) Estimate based on market data compiled by Essity

Concrete progress in sustainability

Leadership in the area of sustainability is a strategic priority for Essity to increase sales and profitability and to reduce risk in the company while we contribute toward a better world. For example, we have launched toilet paper containing wheat straw-based pulp under the Zewa brand and the Libero Touch climate-smart baby diaper. The company's carbon emissions under Science Based Targets, Scope 1 and 2, have been reduced by 18% compared with 2016. Essity also received several awards for the company's sustainability work, for example it was named as one of the world's most sustainable companies by Corporate Knights, has been included in S&P Global's Sustainability Yearbook 2022 as one of the top 150 most sustainable companies and CDP recognized Essity for leadership in sustainability, including us on its
A-list for our work to combat deforestation. For the second consecutive year, we were designated a Diversity Leader by the Financial Times in its annual review of diversity work in European companies.

Priorities 2023

In order to achieve the Group's long-term targets with respect to growth and return by 2025, Essity is prioritizing innovation, strong brands, efficiency improvements and sustainability. We continue to work with price increases to offset cost inflation. Growth in the fastest growing sales channels and regions as well as in segments with the highest returns will be prioritized to create long-term growth in value for customers, consumers, employees and shareholders.

Magnus Groth

President and CEO

FUTURE REPORTS

Essity's Annual Report for 2022 is intended to be published during the week starting February 27, 2023. In 2023, interim reports will be published on April 27, July 20 and October 26. 

ANNUAL GENERAL MEETING

Essity's Annual General Meeting will be held in Stockholm on March 29, 2023.

INVITATION TO PRESENTATION OF THE YEAR-END REPORT FOR 2022

In conjunction with publication, a telephone and web presentation will be held at 09:00 CET, where President and CEO Magnus Groth will present and answer questions.

Presentation

Date: Thursday, January 26, 2023

Time: 09:00 CET

Link to Web presentation: https://essity.videosync.fi/2023-01-26 

Telephone: UK: +44 (0) 33 055 102 00, USA: +1 212 999 66 59, SWE: +46 8 505 204 24. Please call in well in advance of the start of the presentation. Indicate: "Essity".

The presentation of the year-end report will also be available on LinkedIn and Twitter.

Stockholm January 26, 2023
Essity Aktiebolag (publ)

Magnus Groth

President and CEO 

For further information, please contact:

Fredrik Rystedt, CFO and Executive Vice President, +46 8 788 51 31 
Johan Karlsson, Vice President Investor Relations, Group Function Finance, +46 70 511 15 81
Joséphine Edwall Björklund, Chief Communication Officer, Group Function Communications, +46 8 788 52 34
Per Lorentz, Vice President Corporate Communications, Group Function Communications, +46 73 313 30 55

NB:

This report has not been reviewed by the company's auditors.

This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. This report has been prepared in both Swedish and English versions. In case of variations in the content between the two versions, the Swedish version shall govern. The information was submitted for publication, through the agency of Karl Stoltz, Media Relations Director, at 07:00 CET on January 26, 2023.

The following files are available for download:

https://mb.cision.com/Main/15798/3703517/1805403.pdf

The full report (PDF)

 


These press releases may also interest you

at 01:05
Today scientists from Colossal Biosciences, the world's first de-extinction company, and the University of Melbourne announce a major step forward in the effort to save Australia's endangered northern quoll (Dasyurus hallucatus) from the invasive...

at 01:00
Global Heart Hub, the international alliance of heart...

7 mai 2024
Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis strain Plasma [postbiotic] (LC-Plasma) immunization...

7 mai 2024
Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestonesNSG...

7 mai 2024
Today, The Kids Mental Health Foundation (KMHF) hosted a panel alongside the Mental Health Storytelling, which is housed at the USC Annenberg Inclusion Initiative, in New York City. The...

7 mai 2024
The Board of Juno Pharmaceuticals Corporation is excited to announce the appointment of Jean-Guy Goulet as Chief Executive Officer (CEO). An executive with over 35 years of experience in the pharmaceutical industry, overseeing activities in Canada...



News published on and distributed by: